Teva’s merger strains domestic pharmaceutical sector

The rumors that Teva Pharmaceuticals will acquire major stocks of Korea’s mid-tier pharmaceutical firm have strained the pharmaceutical industry here, as Teva is the world's leading generic drug manufacturer known for its hostile takeover bids.

However, industry officials have suspicioned that Teva may have a strong competitiveness in the domestic generic drug market, as Sandoz Korea and Pfi...